 |
| 03-Jan-07 | Initiated |
First Albany |
Buy |
$15.50 |
|
|
|
| 16-May-13 03:59PM | Ophthalmology Innovators: Will InSite Follow Recent Successes? at Seeking Alpha |
| 06:00AM | IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business Unit PR Newswire |
| 11-May-13 01:04PM | IRIDEX CORP Financials EDGAR Online Financials |
| 06-May-13 09:06AM | IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 03-May-13 08:10PM | IRIDEX's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 02-May-13 05:00PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN +6.09% |
| 04:05PM | IRIDEX Reports 2013 First Quarter Results PR Newswire |
| 09:34AM | IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 07:07AM | Q1 2013 IRIDEX Earnings Release - After Market Close CCBN |
| 30-Apr-13 06:30AM | IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries PR Newswire |
| 25-Apr-13 04:05PM | IRIDEX Announces First Quarter 2013 Conference Call and Release Date PR Newswire |
| 03-Apr-13 01:15PM | 4 Healthcare Stock Stories for Wednesday Investment Wellness at Wall St. Cheat Sheet -5.19% |
| 01:04PM | IRIDEX CORP Financials EDGAR Online Financials |
| 02-Apr-13 06:30AM | IRIDEX Announces Global Distribution and Supply Agreement with Peregrine Surgical, Ltd. PR Newswire |
| 28-Mar-13 09:06AM | IRIDEX CORP Files SEC form 10-K, Annual Report EDGAR Online |
| 27-Mar-13 09:12AM | IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 11-Mar-13 10:42AM | Tetra Technologies CFO Buys 11K Shares and 6 Insider Trades to Note at Wall St. Cheat Sheet |
| 04-Mar-13 04:07AM | Iridex Corporation Stock Upgraded (IRIX) at TheStreet |
| 28-Feb-13 05:00PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:32PM | IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:05PM | IRIDEX Reports Record 2012 Fourth Quarter Results PR Newswire |
| 07:07AM | Q4 2012 IRIDEX Earnings Release - After Market Close CCBN |
| 21-Feb-13 04:05PM | IRIDEX Announces Fourth Quarter and Full Year 2012 PR Newswire |
| 19-Feb-13 04:32PM | IRIDEX CORP Files SEC form 8-K/A, Change in Directors or Principal Officers EDGAR Online |
| 22-Jan-13 12:46PM | Iridex sales higher than expected in Q4 at bizjournals.com +5.59% |
| 06:05AM | InPlay: IRIDEX reports preliminary Q4 revs of $9.2 mln (no ests), exceeding high end of guidance Briefing.com |
| 06:00AM | IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End PR Newswire |
| 19-Dec-12 04:47PM | IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 14-Dec-12 06:03AM | IRIDEX announces final results of its tender offer at theflyonthewall.com |
| 06:00AM | IRIDEX Corporation Announces Final Results of its Tender Offer PR Newswire |
| 11-Dec-12 04:09PM | IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 10-Dec-12 06:00AM | IRIDEX Corporation Announces Preliminary Results of its Tender Offer PR Newswire |
| 06-Dec-12 03:41PM | 'Marking the Close': Analysts See Widespread Fund Distortions at Barrons.com |
| 10:06AM | [$$] Fund Managers Lift Results With Timely Trading Sprees at The Wall Street Journal |
| 07:09AM | [$$] Fund Managers Lift Results With Timely Trading Sprees at The Wall Street Journal |
| 05:51AM | [$$] Fund Managers Lift Results With Timely Trading Sprees at The Wall Street Journal |
| 04:18AM | [$$] Fund Managers Lift Results With Timely Trading Sprees at The Wall Street Journal |
| 05-Dec-12 11:13PM | [$$] Fund Managers Lift Results With Timely Trading Sprees at The Wall Street Journal |
| 10:33PM | [$$] Fund Managers Lift Results With Timely Trading Sprees at The Wall Street Journal |
| 04-Dec-12 09:21PM | Galena Reaches Deal with Teva, IRIDEX Wins FDA & CE Approval: Healthcare Business Recap at Wall St. Cheat Sheet |
| 03:31PM | Galena Reaches Deal with Teva, IRIDEX Wins FDA & CE Approval: Healthcare Business Recap at Wall St. Cheat Sheet |
| 03-Dec-12 05:04PM | InPlay: IRIDEX announces FDA 510(k) and CE clearance of new laser delivery system for fast, non-invasive treatment of serious retinal diseases Briefing.com |
| 05:00PM | IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases PR Newswire |
| 14-Nov-12 04:00AM | Iridex Corporation Stock Downgraded (IRIX) at TheStreet |
| 13-Nov-12 04:07PM | IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 10-Nov-12 08:46AM | Isis Optimistic on Pipeline, Myrexis Dissolves Itself: Healthcare Business Recap at Wall St. Cheat Sheet |
| 09-Nov-12 05:41PM | Isis Optimistic on Pipeline, Myrexis Dissolves Itself: Healthcare Business Recap at Wall St. Cheat Sheet |
| 01:04PM | IRIDEX CORP Financials EDGAR Online Financials |
| 06:30AM | IRIDEX Signs Global Licensing Agreement with QUANTEL Medical PR Newswire |
| 07-Nov-12 07:15AM | IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock PR Newswire |
| 05-Nov-12 03:16PM | IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online -5.53% |
| 01-Nov-12 05:00PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:46PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:32PM | IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:05PM | IRIDEX Reports 2012 Third Quarter Results PR Newswire |
| 07:07AM | Q3 2012 IRIDEX Earnings Release - Time Not Supplied CCBN |
| 25-Oct-12 04:05PM | IRIDEX Announces Third Quarter 2012 Conference Call and Release Date PR Newswire |
| 03-Oct-12 05:00AM | Iridex Corporation Stock Upgraded (IRIX) at TheStreet |
| 18-Sep-12 04:07PM | IRIDEX CORP Files SEC form 8-K/A, Change in Directors or Principal Officers EDGAR Online |
| 17-Sep-12 05:06AM | Iridex Corporation Stock Downgraded (IRIX) at TheStreet |
| 11-Sep-12 06:01AM | 5 Healthcare Companies With Insider Buying Filed On August 29 - September 7 at Seeking Alpha |
| 29-Aug-12 06:04AM | IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 28-Aug-12 11:00PM | IRIDEX Appoints Chairman William M. Moore as Interim President & CEO PR Newswire |
| 14-Aug-12 01:04PM | IRIDEX CORP Financials EDGAR Online Financials |
| 07-Aug-12 03:18PM | IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 02-Aug-12 05:00PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN +14.29% |
| 04:32PM | IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:05PM | IRIDEX Reports 2012 Second Quarter Results PR Newswire |
| 07:40AM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 07:07AM | Q2 2012 IRIDEX Earnings Release - After Market Close CCBN |
| 31-Jul-12 04:43PM | Health Care Sector Wrap at Fox Business +8.41% |
| 26-Jul-12 04:05PM | IRIDEX Announces Second Quarter 2012 Conference Call and Release Date PR Newswire |
| 02-Jul-12 05:51PM | Health Care Sector Wrap at Fox Business -10.07% |
| 05:12PM | Health Care Sector Wrap at Fox Business |
| 15-Jun-12 01:05PM | IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 06-Jun-12 06:30AM | IRIDEX Announces First Endo-MicroPulse Laser Surgery PR Newswire |
| 24-May-12 05:00AM | Iridex Corporation Stock Downgraded (IRIX) at TheStreet |
| 12-May-12 01:04PM | IRIDEX CORP Financials EDGAR Online Financials |
| 07-May-12 05:04PM | IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 03-May-12 05:00PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:47PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:42PM | IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:05PM | IRIDEX Reports 2012 First Quarter Results PR Newswire |
| 27-Apr-12 06:30AM | IRIDEX Introduces Non-Invasive MicroPulse Therapy for Glaucoma PR Newswire |
| 26-Apr-12 04:10PM | IRIDEX Announces First Quarter 2012 Conference Call and Release Date PR Newswire |
| 05-Apr-12 01:04PM | IRIDEX CORP Financials EDGAR Online Financials |
| 30-Mar-12 05:15PM | IRIDEX CORP Files SEC form 10-K, Annual Report EDGAR Online |
| 09-Mar-12 06:04PM | Nasdaq stocks posting largest volume increases AP |
| 08-Mar-12 06:10PM | Nasdaq stocks posting largest volume increases AP |
| 02-Mar-12 06:30AM | IRIDEX to Present at Upcoming Investment Conferences PR Newswire |
| 01-Mar-12 05:00PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:46PM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:36PM | IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:05PM | IRIDEX Reports 2011 Fourth Quarter and Year-End Results PR Newswire |
| 07:37AM | IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN |
| 07:07AM | Q4 2011 Iridex Corp Earnings Release - After Market Close CCBN |
| 23-Feb-12 07:15PM | IRIDEX Earnings Call scheduled for Thu, Mar 1 CCBN |
| 04:10PM | IRIDEX Announces Fourth Quarter and Full Year 2011 Conference Call and Release Date PR Newswire |
| 21-Feb-12 04:57PM | IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 06-Feb-12 04:33PM | IRIDEX CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits EDGAR Online +5.60% |
|
|
| IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology worldwide. It provides ophthalmology products that are used in the treatment of serious eye diseases, such as diabetic retinopathy, glaucoma, and age-related macular degeneration. The company's ophthalmic products include consoles, including visible (yellow) photocoagulator, visible (green) photocoagulator, infrared photocoagulator, and micropulse enabled consoles; and multi-wavelength laser system configurations. It also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; operating microscope adapters; EndoProbe, a fiber optic delivery device; G-Probe, a sterile consumable multi-use product; and DioPexy Probe, a hand-held instrument that is used in procedures to treat retinal tears and breaks. In addition, the company's ophthalmic delivery devices and other products comprise GreenTip Soft Tip Cannula, a sterile disposable that allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier, which connects to the air line and provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States and through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| NAUMANN-ETIENNE RUEDIGER | Director | Mar 08 | Buy | 4.80 | 2,400 | 11,520 | 52,796 | Mar 08 06:54 PM | | MOORE WILLIAM M | Chairman and CEO | Mar 07 | Buy | 4.63 | 5,800 | 26,854 | 139,340 | Mar 07 04:28 PM | | ARIAS EDUARDO | Sr. VP, Global Sales | Mar 06 | Option Exercise | 0.90 | 1,877 | 1,689 | 154,902 | Mar 08 04:13 PM | | MOORE WILLIAM M | Chairman and CEO | Mar 06 | Buy | 4.60 | 1,700 | 7,820 | 133,540 | Mar 07 04:28 PM | | ARIAS EDUARDO | Sr. VP, Global Sales | Mar 06 | Sale | 4.63 | 1,075 | 4,977 | 153,827 | Mar 08 04:13 PM | | MOORE WILLIAM M | Chairman and CEO | Mar 05 | Buy | 4.79 | 2,500 | 11,975 | 131,840 | Mar 07 04:28 PM | | Mackaness James H | CFO and COO | Feb 19 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 19 04:21 PM | | Mackaness James H | CFO and COO | Feb 19 | Sale | 4.49 | 3,000 | 13,474 | 2,000 | Feb 19 04:21 PM | | Mackaness James H | CFO and COO | Feb 15 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 19 04:21 PM | | Mackaness James H | CFO and COO | Feb 15 | Sale | 4.61 | 3,000 | 13,833 | 2,000 | Feb 19 04:21 PM | | Mackaness James H | CFO and COO | Feb 14 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 14 05:39 PM | | Mackaness James H | CFO and COO | Feb 14 | Sale | 4.79 | 3,000 | 14,359 | 2,000 | Feb 14 05:39 PM | | Mackaness James H | CFO and COO | Feb 13 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 14 05:39 PM | | Mackaness James H | CFO and COO | Feb 13 | Sale | 4.70 | 3,000 | 14,100 | 2,000 | Feb 14 05:39 PM | | Mackaness James H | CFO and COO | Feb 12 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 14 05:39 PM | | Mackaness James H | CFO and COO | Feb 12 | Sale | 4.83 | 3,000 | 14,492 | 2,000 | Feb 14 05:39 PM | | Mackaness James H | CFO & COO | Feb 11 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 11 06:32 PM | | Mackaness James H | CFO & COO | Feb 11 | Sale | 4.73 | 3,000 | 14,188 | 2,000 | Feb 11 06:32 PM | | Mackaness James H | CFO & COO | Feb 08 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 11 06:32 PM | | Mackaness James H | CFO & COO | Feb 08 | Sale | 4.49 | 3,000 | 13,474 | 2,000 | Feb 11 06:32 PM | | Mackaness James H | Chief Financial Officer | Feb 07 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 07 05:22 PM | | Mackaness James H | Chief Financial Officer | Feb 07 | Sale | 4.66 | 3,000 | 13,975 | 2,000 | Feb 07 05:22 PM | | Mackaness James H | Chief Financial Officer | Feb 06 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 07 05:22 PM | | Mackaness James H | Chief Financial Officer | Feb 06 | Sale | 4.71 | 3,000 | 14,122 | 2,000 | Feb 07 05:22 PM | | Mackaness James H | Chief Financial Officer | Feb 05 | Option Exercise | 2.49 | 3,000 | 7,470 | 5,000 | Feb 07 05:22 PM | | ARIAS EDUARDO | Sr. VP, Global Sales | Feb 05 | Sale | 5.00 | 3,900 | 19,500 | 153,025 | Feb 07 05:28 PM | | Mackaness James H | Chief Financial Officer | Feb 05 | Sale | 4.71 | 3,000 | 14,122 | 2,000 | Feb 07 05:22 PM | | MOORE WILLIAM M | Chairman and CEO | Sep 06 | Buy | 3.77 | 9,800 | 36,946 | 73,944 | Sep 07 04:18 PM | | MOORE WILLIAM M | Chairman and CEO | Sep 05 | Buy | 3.50 | 200 | 700 | 64,144 | Sep 07 04:18 PM | | NAUMANN-ETIENNE RUEDIGER | Director | May 21 | Sale | 4.15 | 300 | 1,245 | 64,019 | May 24 05:20 PM |
|
|
|
|
|
|
